summari due report result wednesday octob
expect anoth strong quarter term
organ sale adj ep growth model sale
organ consensu adj
ep consensu given
underli momentum busi would expect top-lin
organ growth come least in-lin estim
organ addit updat model
new mitraclip estim post-coapt see figur revis
 libr forecast see detail fx punchlin
fx appear headwind
increas confid durabl abt robust
growth driven part mitraclip libr rais
organ growth estim
regard fx model
headwind sale vs prior translat
hit adj ep estim model
estim fx headwind top-
linebut leav adj ep estim unchang
given top-lin strength expect
abl larg mitig impact fx bottom-lin
previous model includ impact fx
forecast publicli state start everi year
double-digit report ep growth target expect
case
expect strong print model sale
organ consensu adj
ep consensu comp
adjust basi organ growth estim repres
acceler versu refer guid
organ growth mid-single-digit msd high-single-digit
hsd adj ep model medic devic
growth ex-fx guidanc hsd growth nutrit
growth guidanc msd growth epd establish
pharmaceut divis growth ex-fx guidanc msd
hsd growth diagnost growth ex-fx ex-alr
guidanc msd hsd growth word
anticip major surpris quarter
respect busi altogeth would expect organ
growth come least in-lin organ
estim bottom-lin would expect adj ep
least in-lin estim
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort intang ep continu
oper ep includ stj amo alr deal
forecast includ stj acquisit alr deal amo divestitur
compani data secur llc estim reuter
new mitraclip libr forecast mention revis estim mitraclip
libr two import growth driver mitraclip took ou forecast
account compel coapt result last month tct transcathet cardiovascular
expect fmr function mitral regurgit indic next year model
ww mitraclip sale ex-fx respect
compar previou forecast respect left
mitraclip forecast unchang view new mitraclip estim conserv reflect
uncertainti around exact time fda approv fmr indic subsequ re-
open ncd nation coverag decis center medicar medicaid servic
regard libr took estim year model libr sale
vs prior vs prior vs prior
altogeth model med devic growth ex-fx respect
recal state recent investor meet tct expect medic devic busi
grow high singl digit next coupl year
 incom statement million except per share forma stj alr amo good sold fit fit includ includ med-tech fit fit includ expens fx loss expens ep continu ep includ discontinu analysiscost good margin margin fit fit compani report secur llc estim medic technolog
mr mitral regurgit patient popul eu popul year old patient w/ mr moderate-to-sever patient moderate-to-sever mr patient elig treatment mr patient elig treatment mr degen mitral regurgit mr patient m/ dmr patient w/ mr dmr patient treat dmr total dmr patient treat via transcathet total dmr patient treat penetr total dmr asp dmr tmvr market y/i function mitral regurgit mr patient m/ fmr patient w/ mr fmr patient treat fmr total fmr patient treat via transcathet total fmr patient treat penetr total fmr asp fmr tmvr market y/i patient mr treat m/ patient treat mr patient treat via transcathet y/i patient treat penetr surgeri transcathet asp total tmvr market y/i sale y/i tmvr includ transcathet mitral valv replac repair technologiessourc compani report well fargo secur llc estim abbott laboratori
price target nc
price target base ep estim risk target includ
slower growth key busi market delay stj alr integr slower margin
expect continu deliv double-digit underli ep growth mid-singl digit underli
sale growth oper leverag
abbott laboratori diversifi global medic product compani four key busi segment
nutrit diagnost establish pharmaceut epd medic devic compani report
total revenu compani acquir stj januari nearli doubl
